ADP-Induced Platelet Release Reaction in Acute Stroke

Summary

The extent of the ADP-induced platelet release reaction has been determined in 107 patients admitted to hospital with acute stroke. In 43 of the patients a precise diagnosis was obtained and in those with proven thromboembolic stroke the mean extent of the release reaction was significantly higher than for those with either primary haemorrhagic stroke or those with subarachnoid haemorrhage. Enhanced platelet reactivity was also found in the patients in whom a precise diagnosis could not be obtained, most of whom probably had cerebral infarction. Comparison of the results obtained for patients with stroke with those obtained for individuals who had not experienced a stroke showed that thromboembolic stroke is associated with platelet hyperactivity while haemorrhagic stroke is associated with platelet hypoactivity. The part that abnormalities of platelet behaviour, whether causal or consequential, might play in occlusive stroke and intra-cranial haemorrhage is discussed and the need for large scale prospective studies is emphasised.

Keywords

Blood platelets - Thromboembolic stroke - Primary haemorrhagic stroke - Subarachnoid haemorrhage

• References

• 1 Heptinstall S, Mulley GP, Taylor PM, Mitchell JR A. Platelet release reaction in myocardial infarction. Br Med J 1980; 1: 80-82
• 2 Kalendovsky Z, Austin J, Steele P. Increased platelet aggregability in young patients with stroke: diagnosis and therapy. Arch Neurol 1975; 32: 13-21
• 3 Dougherty JH, Levy DE, Weksler BB. Platelet activation in acute cerebral ischaemia. Serial measurements of platelet function in cerebrovascular disease Lancet 1977; 1: 821-824
• 4 Levine PH, Fisher M, Fullerton AL, Duffy CP, Hoogasian JJ. Human platelet factor 4: preparation from outdated platelet concentrates and application in cerebral vascular disease. Am J Hematol 1981; 10: 375-385
• 5 Mettinger KL, Egberg N. A study of hemostasis in ischemic cerebrovascular disease. II. Abnormalities in platelet ADP release, platelet cyclo-oxygenase regeneration time and platelet factor 3 availability. Thromb Res 1982; 26: 193-201
• 6 Danta G. Second phase platelet aggregation induced by adenosine diphosphate in patients with cerebral vascular disease and in control subjects. Thrombos Diathes Haemorrh 1970; 23: 159-169
• 7 Sano T, Boxer MG J, Boxer LA, Yokoyama M. Platelet sensitivity to aggregation in normal and diseased groups. Thrombos Diathes Haemorrh 1971; 25: 524-531
• 8 Lou HC, Nielsen JD, Bomhold A, Gormsen J. Platelet hyperaggregability in young patients with completed stroke. Acta Neurol Scand 1977; 56: 326-334
• 9 Ten CateJ, Vos J, Oosterhuis H, Prenger D, Jenkins CS P. Spontaneous platelet aggregation in cerebrovascular disease. Thrombos Diathes Haemorrh 1978; 39: 223-229
• 10 Mettinger KL, Nyman D, Kjellin KG, Siden A, Söderström CE. Factor VIII related antigen, antithrombin III, spontaneous platelet aggregation and plasminogen activator in ischemic cerebrovascular disease. J Neurol Sci 1979; 41: 31-38
• 11 Bazan NG. Effects of ischemia and electroconvulsive shock on free fatty acid pool in brain. Biochim Biophys Acta 1970; 218: 1-10
• 12 Zervas NT, Lavyne MH, Negoro M. Neurotransmitters and the normal and ischemic cerebral circulation. N Engl J Med 1975; 293: 812-816
• 13 Petrova TR, Pavlishchuk SA, Grigoriev GL. Phase analysis of platelet aggregation in acute disturbances of cerebral circulation. Cor Vasa 1975; 17: 102-111
• 14 Kobayashi I, Fujita T, Yamazaki H. Platelet aggregability measured by screen filtration pressure method in cerebrovascular disease. Stroke 1976; 7: 406-409